Ajanta Pharma Ltd (AJANTPHARM) — Sustainability Report | 30 September 2026

30 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Ajanta Pharma submits FY 2025-26 Sustainability Report to BSE

🔄 What Changed

Renewable energy capacity increased to 16.6 MW; Scope 1 emissions reduced by 47%; CSR spend rose 18.1% above statutory obligation; women on board increased to 25%; hazardous waste co-processing reached 99%; AI-risk identification initiated

🔮 What's Next

Targets include 50% renewable energy by FY 2027, 100% by FY 2032, 20% Scope 1 and 2 emissions reduction by March 2027, 1.5 lakh KL water conservation potential by FY 2027, and 15% women board representation by 2030

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

Ajanta Pharma submitted its FY 2025-26 Sustainability Report, detailing ESG performance across environmental, social and governance metrics. The report highlights progress in renewable energy adoption, emissions reduction, water stewardship, waste management and community impact, aligning with GRI standards and SEBI BRSR requirements. It underscores the company’s commitment to sustainable growth, responsible governance and stakeholder engagement, with external assurance provided by TÜV India.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Ltd (AJANTPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹44,452.1 CrP/E: 39.2ROE: 25.1%ROCE: 31.8%Div Yield: 0.79%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"How will Ajanta Pharma achieve 50% renewable energy by FY 2027?""What is the financial impact of 18.1% above statutory CSR spend?""How does AI-risk identification affect R&D and supply chain operations?"

Ask AI Free →

📊 More AJANTPHARM filings

🔴 Insider Trading — 28 September 2026Promoter Aayush Agrawal released pledges on 98,185 shares of Ajanta Pharma Ltd on 28 September 2026 ...
Announcement — 25 September 2026Ajanta Pharma announced that its insider trading window will close on 1 October 2026 and remain shut...
Announcement — 31 August 2026Ajanta Pharma announced its schedule for upcoming investor meetings with Jefferies India Forum on Se...
🔴 Insider Trading — 27 August 2026Ajanta Pharma Ltd disclosed that promoter group entities including Yogesh Agrawal Trust, Rajesh Agra...
Announcement — 5 August 2026Ajanta Pharma announced its schedule for analyst and institutional investor meetings in August 2026,...

See all AJANTPHARM filings →

🔥 Also filed on 30 September 2026

SEAMECLTDSEAMEC LtdAnnouncement BLUECLOUDSBlue Cloud Softech Solutions LtdAnnouncement DEEPADeepa Jewellers LtdFinancial Results HEGAMHEG Advanced Materials LtdAnnouncement INOXGREENInox Green Energy Services LtdCorporate Action 543435Clara Industries LtdBoard Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.